Loading...

Loading...

COFEPRIS’s New Molecules Registry Updated
By Miriam Bello - Tue, 06/29/2021 - 12:53
COFEPRIS’s recent update is expected to spur innovation on drug therapies and encourage investment on innovation.
https://mexicobusiness.news/tag/marco-ruggiero
More Health
UNOPS Brings Savings, Unfulfilled Contracts, Medicine Shortages
By Miriam Bello - Tue, 06/01/2021 - 15:05
Changes to medicines purchasing schemes brought savings but also several problems.
Medical Devices, Pharmaceutical Production: Pillars for Recovery
By Miriam Bello - Fri, 04/30/2021 - 14:17
Experts agree the health industry will play a key role in helping the country brave both its health and economic crises.
Innovation to Relieve a Suffocated Sector
By Miriam Bello - Fri, 04/16/2021 - 09:23
Chiesi’s priorities focus on propelling innovation in Mexico by breaking bureaucratic barriers that slow progress.
 How to Thrive in the New Centralized Purchasing Schemes
By Mónica López - Mon, 02/15/2021 - 11:59
Industry players unite to solve the current health situation in Mexico. Mexico Health Summit covers the government’s centralized purchasing scheme.
Dialogue is Essential to Ensure Quality Treatments: Chiesi
By Jan Hogewoning - Wed, 01/27/2021 - 21:07
Director General of Chiesi Mexico, Marco Ruggiero explains how medicine purchasing schemes have impacted the industry and Chiesi's place as a provider
How to Thrive in the New Centralized Purchasing Schemes
By Miriam Bello - Wed, 01/27/2021 - 13:41
Industry players unite to solve the current health situation in Mexico. Mexico Health Summit covers the government’s centralized purchasing scheme.
How Has the Centralized Medicine Purchasing Scheme Worked So Far?
By Miriam Bello - Wed, 07/08/2020 - 16:44
The healthcare sector grabbed the spotlight in Mexico before COVID-19, as public entities faced medicine shortages. Here is what happened.
Better Practices Lead to Greater Profits
By Miriam Bello - Mon, 04/20/2020 - 17:11
Marco Ruggiero explains how good work and practices have translated on being the first pharmaceutical company on having B Corp ertification
Focus Should Be on Total Treatment Cost Not Drug Cost
By - Wed, 06/05/2019 - 18:30
Chiesi Group is a pharmaceutical manufacturer founded in Italy in 1935.